Yaewon Yang

969 total citations
54 papers, 688 citations indexed

About

Yaewon Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yaewon Yang has authored 54 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Yaewon Yang's work include Cancer Treatment and Pharmacology (8 papers), Advanced Breast Cancer Therapies (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Yaewon Yang is often cited by papers focused on Cancer Treatment and Pharmacology (8 papers), Advanced Breast Cancer Therapies (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Yaewon Yang collaborates with scholars based in South Korea, United States and Ethiopia. Yaewon Yang's co-authors include Seock‐Ah Im, Bhumsuk Keam, Ahrum Min, Hye Sook Han, Do‐Youn Oh, Seongyeong Kim, Jihyun Kwon, Yung‐Jue Bang, Mark J. O’Connor and Hyemin Jang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yaewon Yang

51 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaewon Yang South Korea 13 380 258 147 141 125 54 688
Charlotte Lemech Australia 16 389 1.0× 262 1.0× 146 1.0× 114 0.8× 81 0.6× 63 695
Khalil Choucair United States 12 234 0.6× 337 1.3× 108 0.7× 178 1.3× 124 1.0× 36 693
Kimberley M. Heinhuis Netherlands 10 508 1.3× 202 0.8× 261 1.8× 197 1.4× 87 0.7× 15 797
Michela Maur Italy 14 437 1.1× 208 0.8× 111 0.8× 194 1.4× 91 0.7× 26 666
George Philips United States 15 386 1.0× 301 1.2× 150 1.0× 254 1.8× 117 0.9× 41 916
Chiara Spoto Italy 10 279 0.7× 131 0.5× 155 1.1× 109 0.8× 123 1.0× 13 584
Jean Pierre Delord France 13 514 1.4× 233 0.9× 90 0.6× 185 1.3× 57 0.5× 20 792
Akiyuki Hirosue Japan 17 347 0.9× 356 1.4× 179 1.2× 73 0.5× 209 1.7× 42 822
Deanna Teoh United States 12 173 0.5× 253 1.0× 87 0.6× 74 0.5× 87 0.7× 20 708
T. Geldart United Kingdom 15 293 0.8× 202 0.8× 122 0.8× 178 1.3× 53 0.4× 40 642

Countries citing papers authored by Yaewon Yang

Since Specialization
Citations

This map shows the geographic impact of Yaewon Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaewon Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaewon Yang more than expected).

Fields of papers citing papers by Yaewon Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaewon Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaewon Yang. The network helps show where Yaewon Yang may publish in the future.

Co-authorship network of co-authors of Yaewon Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaewon Yang. A scholar is included among the top collaborators of Yaewon Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaewon Yang. Yaewon Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hong-Sik, Minsuk Kwon, Seung-Myoung Son, et al.. (2025). Distinct Immunosuppressive Tumor Microenvironment in Gastric Cancer With Peritoneal Metastasis. Journal of the Korean Gastric Cancer Association. 25(4). 605–605. 1 indexed citations
2.
Kang, Eun Joo, Yaewon Yang, Sang-Ho Lee, et al.. (2024). A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17). ESMO Open. 9(9). 103668–103668. 2 indexed citations
3.
Son, Seung-Myoung, Chang Gok Woo, Hongsik Kim, et al.. (2024). Discordance in Claudin 18.2 Expression Between Primary and Metastatic Lesions in Patients With Gastric Cancer. Journal of the Korean Gastric Cancer Association. 25(2). 303–303. 3 indexed citations
4.
Yang, Yaewon, Jisun Lee, Chang Gok Woo, Ok-Jun Lee, & Seung-Myoung Son. (2024). Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report . Diagnostic Pathology. 19(1). 4 indexed citations
5.
Yang, Yaewon, Eun Joo Kang, Yu Jung Kim, et al.. (2024). ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17).. Journal of Clinical Oncology. 42(16_suppl). 3050–3050. 1 indexed citations
6.
Kim, Hong-Sik, In‐Gu Do, Hee Kyung Kim, et al.. (2024). Novel diagnostic biomarkers for pancreatic cancer: assessing methylation status with epigenetic-specific peptide nucleic acid and KRAS mutation in cell-free DNA. Frontiers in Oncology. 14. 1395473–1395473. 5 indexed citations
7.
Lim, Yoojoo, Chan‐Young Ock, Gahee Park, et al.. (2023). Artificial intelligence‐powered spatial analysis of tumor‐infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma. Head & Neck. 45(12). 3086–3095. 5 indexed citations
8.
Yang, Yaewon, Se‐Il Go, Woo Kyun Bae, et al.. (2022). Diagnostic Value of Ascitic Tumor Markers for Gastric Cancer-associated Malignant Ascites. SHILAP Revista de lepidopterología. 22(1). 38–49. 2 indexed citations
9.
Kang, Eun Joo, Myung‐Ju Ahn, Chan-Young Ock, et al.. (2021). Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma. Clinical Cancer Research. 27(19). 5272–5279. 39 indexed citations
10.
Go, Se‐Il, Sang‐Cheol Lee, Woo Kyun Bae, et al.. (2021). Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). European Journal of Cancer. 157. 21–30. 17 indexed citations
11.
Park, Hee Sue, Kyeong Seob Shin, Seonggyu Byeon, et al.. (2021). The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents. Acta Haematologica. 144(6). 649–659. 2 indexed citations
12.
Yang, Yaewon, Ahrum Min, Kyung-Hun Lee, et al.. (2020). Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients. Journal of Breast Cancer. 23(2). 182–182. 9 indexed citations
13.
Yun, Jieun, Sang‐Bae Han, Hong Jun Kim, et al.. (2019). Exosomal miR-181b-5p Downregulation in Ascites Serves as a Potential Diagnostic Biomarker for Gastric Cancer-associated Malignant Ascites. Journal of the Korean Gastric Cancer Association. 19(3). 301–301. 27 indexed citations
14.
Kim, Hong-Sik, Seung-Myoung Son, Chang Gok Woo, et al.. (2019). Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions. BMC Cancer. 19(1). 834–834. 2 indexed citations
15.
Min, Ahrum, Hyemin Jang, Seongyeong Kim, et al.. (2018). Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage Response. Molecular Cancer Therapeutics. 17(12). 2507–2518. 15 indexed citations
16.
Min, Ahrum, Seock‐Ah Im, Hyemin Jang, et al.. (2017). AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells. Molecular Cancer Therapeutics. 16(4). 566–577. 105 indexed citations
17.
Yang, Yaewon, Tae Min Kim, Yong‐Oon Ahn, et al.. (2016). Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors. Cancer Immunology Research. 4(3). 215–224. 128 indexed citations
18.
Kim, Hee‐Jun, Ahrum Min, Seock‐Ah Im, et al.. (2016). Anti‐tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells. International Journal of Cancer. 140(1). 109–119. 49 indexed citations
19.
Beom, Seung‐Hoon, Jisu Oh, Tae‐Yong Kim, et al.. (2016). Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea. Cancer Research and Treatment. 49(2). 454–463. 2 indexed citations
20.
Yang, Yaewon, Young Ae Kang, Seung‐Hoon Lee, et al.. (2007). Aetiologies and predictors of pulmonary cavities in South Korea.. PubMed. 11(4). 457–62. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026